-
Exploring Ferumoxytol: A Frontier in MRI Contrast Agents
29 Mar 2024 22:06 GMT
… cells, and assessing inflammation.
Enter Ferumoxytol: a superparamagnetic iron oxide nanoparticle … its clinical introduction in 2009, Ferumoxytol-enhanced MRI (FE-MRI) has … -MRI practices. Compared to GBCAs, Ferumoxytol stands out for its excellent …
-
Withdrawn application: Feraheme, ferumoxytol, Date of withdrawal: 09/03/2023, Initial authorisation
30 Mar 2023 14:41 GMT
… the main studies showed that Feraheme was effective at treating … the effectiveness and safety of Feraheme, to which the company … to provide satisfactory answers before Feraheme could be authorised. At … was that the benefits of Feraheme did not outweigh its …
-
Syngene Proposal To Conduct Phase I CT of Ferumoxytol Inj rejected by CDSCO panel
26 Mar 2023 19:44 GMT
… I clinical trial of Ferumoxytol injection.
The drug to … I clinical trial of Ferumoxytol Injection (30 mg… mL) before the committee.
Ferumoxytol is an intravenous iron replacement … chronic kidney disease (CKD).
Ferumoxytol consists of superparamagnetic iron …
-
Sandoz introduces generic ferumoxytol injection in US to treat patients with iron deficiency anemia
19 Jul 2021 12:21 GMT
… immediate US availability of generic ferumoxytol, an intravenous medicine used to … generic equivalent to AMAG Pharmaceuticals’ Feraheme (ferumoxytol injection), is approved to treat … iron available in the US, ferumoxytol provides patients with iron deficiency …
-
Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia
16 Jul 2021 13:34 GMT
… to AMAG Pharmaceuticals' Feraheme®* (ferumoxytol injection), is approved to …
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
Ferumoxytol is contraindicated in patients … hypotension following the administration of Ferumoxytol.
Iron Overload: Regularly …
-
Feraheme (ferumoxytol; AMAG Pharmaceuticals) Drug Analysis 2018 - ResearchAndMarkets.com
21 Feb 2018 20:19 GMT
… ResearchAndMarkets.com's
offering.
Feraheme (ferumoxytol; AMAG Pharmaceuticals) is an … a significant commercial
disadvantage. Feraheme will have difficulty competing against … Key Topics Covered:
Product Profiles
Feraheme: Anemia in chronic kidney disease …
-
AMAG Pharmaceuticals Announces FDA Approval of Feraheme (ferumoxytol injection) for All Eligible Adult Patients with Iron Deficiency Anemia
14 Feb 2018 00:50 GMT
… broaden the existing label for Feraheme (ferumoxytol injection) beyond the current … qualify for help.
About Feraheme (ferumoxytol injection)
Feraheme received marketing approval from … February 2018
Related Articles:
Feraheme (ferumoxytol) FDA Approval History
-
AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme® (ferumoxytol injection)
05 Feb 2018 13:00 GMT
… broaden the existing label for Feraheme® (ferumoxytol injection) beyond the current … who meet the broader ferumoxytol injection indication that can … qualify for help. About Feraheme® (ferumoxytol injection)
Feraheme received marketing approval from …
-
AMAG Announces U.S. FDA Filing Acceptance and Six-Month Review of Feraheme® (ferumoxytol) for the Treatment of All Adult Patients With Iron Deficiency Anemia
31 Aug 2017 12:00 GMT
… broaden the existing label for Feraheme® (ferumoxytol) to include the treatment of … results please click here. About Feraheme® (ferumoxytol)
Feraheme received marketing approval from the … the U.S. shortly thereafter. Ferumoxytol is protected in the U …
-
AMAG Completes Feraheme® (ferumoxytol) FDA Submission for the Treatment of All Adult Patients With Iron Deficiency Anemia
03 Aug 2017 11:00 GMT
… existing label for Feraheme® (ferumoxytol) to include the … 35.15%). About Feraheme® (ferumoxytol)
Feraheme received marketing approval from … . shortly thereafter. Ferumoxytol is protected in … #47;cardiorespiratory arrest. Feraheme is contraindicated in patients …